Literature DB >> 15023080

Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation.

Larissa A Munishkina1, Jeremy Henriques, Vladimir N Uversky, Anthony L Fink.   

Abstract

Deposition of misfolded alpha-synuclein is a critical factor in several neurodegenerative disorders. Filamentous alpha-synuclein is the major component of Lewy bodies and Lewy neurites, the intracellular inclusions in the dopaminergic neurons of the substantia nigra, which are considered the pathological hallmark of Parkinson's disease. We show here that anions induce partial folding of alpha-synuclein at neutral pH, forming a critical amyloidogenic intermediate, which leads to significant acceleration of the rate of fibrillation. The magnitude of the accelerating effect generally followed the position of the anions in the Hofmeister series, indicating a major role of protein-water-anion interactions in the process at salt concentrations above 10 mM. Below this concentration, electrostatic effects dominated in the mechanism of anion-induced fibrillation. The acceleration of fibrillation by anions was also dependent on the cation. Moderate concentrations of anions affected both the rates of nucleation and the elongation of alpha-synuclein fibrillation, primarily via their effect on the interaction of the protein with water.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023080     DOI: 10.1021/bi034938r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  63 in total

1.  Semisynthetic, site-specific ubiquitin modification of α-synuclein reveals differential effects on aggregation.

Authors:  Franziska Meier; Tharindumala Abeywardana; Abhinav Dhall; Nicholas P Marotta; Jobin Varkey; Ralf Langen; Champak Chatterjee; Matthew R Pratt
Journal:  J Am Chem Soc       Date:  2012-03-14       Impact factor: 15.419

2.  An equilibrium model for linear and closed-loop amyloid fibril formation.

Authors:  Shuo Yang; Michael D W Griffin; Katrina J Binger; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2012-02-24       Impact factor: 5.469

3.  Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloid fibrils.

Authors:  Timothy M Ryan; Chai L Teoh; Michael D W Griffin; Michael F Bailey; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2010-04-28       Impact factor: 5.469

4.  Environmental conditions affect the kinetics of nucleation of amyloid fibrils and determine their morphology.

Authors:  Bertrand Morel; Lorena Varela; Ana I Azuaga; Francisco Conejero-Lara
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

5.  Protein particulates: another generic form of protein aggregation?

Authors:  Mark R H Krebs; Glyn L Devlin; A M Donald
Journal:  Biophys J       Date:  2006-11-17       Impact factor: 4.033

Review 6.  Amyloid-a state in many guises: survival of the fittest fibril fold.

Authors:  Jesper S Pedersen; Daniel E Otzen
Journal:  Protein Sci       Date:  2007-11-27       Impact factor: 6.725

7.  Thermal aggregation of bovine serum albumin at different pH: comparison with human serum albumin.

Authors:  Valeria Vetri; Fabio Librizzi; Maurizio Leone; Valeria Militello
Journal:  Eur Biophys J       Date:  2007-07-12       Impact factor: 1.733

Review 8.  Amyloidogenesis of natively unfolded proteins.

Authors:  Vladimir N Uversky
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

9.  Ion-specific effects on prion nucleation and strain formation.

Authors:  Jonathan Rubin; Hasan Khosravi; Kathryn L Bruce; Megan E Lydon; Sven H Behrens; Yury O Chernoff; Andreas S Bommarius
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

10.  Ion-specific modulation of protein interactions: anion-induced, reversible oligomerization of a fusion protein.

Authors:  Yatin R Gokarn; R Matthew Fesinmeyer; Atul Saluja; Shawn Cao; Jane Dankberg; Andrew Goetze; Richard L Remmele; Linda O Narhi; David N Brems
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.